Christopher Bartley is the Managing Director of Waisman Biomanufacturing, bringing over 20 years of experience in research and product development. With a B.S. in Bacteriology from the University of Wisconsin-Madison, he has played a key role in developing and manufacturing biologics, specializing in fermentation, bioreactor controls, and downstream processing.

Scott Smith, Director of Operations at Waisman Biomanufacturing, brings over two decades of progressive leadership in biomanufacturing and operations management within the biotechnology and pharmaceutical sectors. With a Bachelor of Science in Management and an Associate of Applied Science in Biotechnology, Scott has cultivated deep expertise in upstream and downstream cGMP manufacturing, fermentation, and protein purification.

Brian Dattilo, Ph.D., is the Director of Business Development at Waisman Biomanufacturing, bringing extensive experience in recombinant protein production and biopharmaceutical development. With a background in both public service and industry, he specializes in client engagement, technical product development, and strategic investment in novel platform technologies.

John Vedo, Director of Quality Assurance at Waisman Biomanufacturing, brings 20 years of experience in pharmaceutical and biotech cGMP environments. With a B.S. in Biology from Indiana University and an M.B.A. from DePaul University, he leads a team of quality professionals to ensure regulatory compliance and uphold industry standards.

Rita Stiemke, Ph.D., is the Director of Quality Control at Waisman Biomanufacturing, bringing extensive experience in cGMP-compliant quality testing, method development, and validation for biopharmaceutical products. With a background in chemical engineering and pharmaceutical sciences, she leads a team of QC specialists to ensure rigorous product release and stability testing in collaboration with clients and internal teams.